Watch and learn from the leading researchers in cannabis genomics and clinical applications, how advanced molecular tools impact real-life use – cases in seed and clone development. The experts on the panel share how they use molecular tools to advance cannabis research and varieties development.
- Jonathan Vaught, PhD CEO & Founder at Front Range Biosciences
- Professor Dedi Meiri Associate Professor, Faculty of Biology at the Technion
- Oori Weisshaus, PhD Director of Genomic Solutions at NRGene
- Reggie Gaudino, PhD VP Research & Development at Front Range Biosciences
- Saul Kaye, Founder & CEO at iCAN: Israel-Cannabis
CTOs, CSOs and CEOs of cannabis breeding companies, cannabis multi-state operators, genetic researchers, hemp growers, seed suppliers, and others. Owners and finance experts in the space will benefit from the use cases being shared.
REGISTER TO VIEW WEBINAR
Meet the Experts
Jonathan Vaught, PhD
CEO & FOUNDER
Front Range Biosciences
Dr. Vaught co-founded Front Range Biosciences with a deep belief in the importance of sustainable agriculture to improve human health and nutrition. An innovative problem solver with 15 years of experience developing and commercializing technologies for human diagnostics, food safety and agriculture, Dr. Vaught brings a diverse background with a strong scientific and practical business acumen. As CEO Dr. Vaught has built a team committed to bringing the best of modern agriculture to high-value crops to improve reliability, efficiency and safety for farmers and consumers.
Professor Dedi Meiri
Faculty of Biology, Technion
David Meiri, PhD, is Associate Professor at the Faculty of Biology at the Technion and a member of the Technion Integrated Cancer Center (TICC). Dr. Meiri holds a M.Sc. in Biochemistry and a Ph.D. in plant biotechnology from Tel Aviv University. He conducted his post-doctoral fellowship at the Ontario Cancer Institute where he focused on tumor invasion and metastasis.
In addition to the laboratory cannabis research performed onsite, Dr. Meiri collaborates with cannabis growers, clinicians, major manufacturers and distributors of medical cannabis for the purpose of revolutionizing cannabis treatment. He is operating the “Cannabis Database Project” and his lab is currently involved in eight clinical trials covering diverse aspects of cannabis treatment such as colon disease, pain prevention, cancer treatment and epilepsy.
Oori Weishauss, PhD
Director of genomic solutions
Dr. Oori Weishauss is with NRGene since 2011, applying genomic tools for marker development in breeding projects of various crops. In the last several years he has specialized in cannabis genetics and become an expert in the field. Oori holds a PhD in plant and microbial genetics from the Hebrew University; his academic background is in genetics of plant secondary metabolism pathways.
Reggie Gaudino, PhD
VP Research & Development
Front Range Biosciences
Dr. Gaudino oversees the cannabis genetics and scientific research division for Front Range Biosciences. Formerly the President at Steep Hill, the acquisition of Reggie and his team has significantly advanced FRB’s breeding program, resulting in additional unique and advantaged cannabis and hemp varieties. Dr. Gaudino believes that by using science and technology to help customers succeed and increase profits, FRB can build stronger relationships and be a better partner for customers.
CEO & Founder
Saul Kaye is the founder and CEO of iCAN: Israel-Cannabis and a true leader in the Global Cannabis Ecosystem. Saul is an industry advisor to the Medical Cannabis Caucus of the Knesset as well as an advisor to the Ministries of Economy and Health in Israel. Saul is a licensed pharmacist and a successful entrepreneur with both retail and e-commerce experience, and has founded multiple companies spanning six countries across the US, Europe, Israel and Australia.